期刊
VOX SANGUINIS
卷 105, 期 2, 页码 177-180出版社
WILEY-BLACKWELL
DOI: 10.1111/vox.12029
关键词
mass spectrometry; proteomics; red cell components; transfusion medicine (in general)
类别
资金
- Italian National Blood Centre (Centro Nazionale Sangue - CNS - Istituto Superiore Sanita' - Rome, Italy)
- Interuniversity Consortium for Biotechnology (CIB)
Haemoglobin A(1c) (HbA(1c)) represents a key biomarker in diabetes diagnosis and management, as it is indicative of recent blood glucose concentrations. Glycation of haemoglobin is a non-enzymatic irreversible process that is promoted by the prolonged exposure of erythrocytes to high glucose concentrations, a condition that is known to occur under blood banking conditions. However, controversial data indicate no clear hint as to whether and to which extent HbA(1c) accumulates during red blood cell storage. Hereby, we propose the application of a validated MALDI-TOF mass-spectrometry-based method to this issue and report the observation about HbA(1c) levels apparently increasing over storage progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据